← Back to Search
Alteration Of The Sphingomyelin/Ceramide Pathway Is Associated With Resistance Of Human Breast Carcinoma MCF7 Cells To Tumor Necrosis Factor-α-mediated Cytotoxicity*
Z. Cai, A. Bettaieb, N. E. Mahdani, L. Legrès, R. Stancou, J. Masliah, S. Chouaib
Published 1997 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The interference of tumor necrosis factor-α (TNF) signaling processes with the acquisition of tumor resistance to TNF was investigated using the TNF-sensitive human breast carcinoma MCF7 cell line and its established TNF-resistant variant (R-A1). The resistance of R-A1 cells to TNF correlated with a low level of p55 TNF receptor expression and an absence of TNF signaling through TNF receptors. Stable transfection of wild-type p55 receptor in R-A1 resulted in enhancement of p55 expression and in partial restoration of TNF signaling, including nuclear factor-κB (NF-κB) activation. However, the transfected cells remained resistant to TNF-induced apoptosis. Northern blot analysis revealed a comparable induction of manganous superoxide dismutase and A20 mRNA expression in p55-transfected cells and in sensitive MCF7 cells, making it unlikely that these genes are involved in the resistance to TNF-mediated cytotoxicity. While TNF significantly stimulated both neutral and acidic sphingomyelinase (SMase) activities with concomitant sphingomyelin (SM) hydrolysis and ceramide generation in MCF7, it failed to trigger these events in TNF-resistant p55-transfected cells. In addition, the basal SM content was significantly higher in sensitive MCF7 as compared to the resistant counterparts. Furthermore, the TNF-resistant cells tested could be induced to undergo cell death after exposure to exogenous SMase or cell-permeable C6-ceramide. This study also shows that TNF failed to induce arachidonic acid release in p55-transfected resistant cells, suggesting that an alteration of phospholipase A2 activation may be associated with MCF7 cell resistance to TNF. Our findings strongly suggest a role of ceramide in the mechanism of cell resistance to TNF-mediated cell death and may be relevant in elucidating the biochemical nature of intracellular messengers leading to such resistance.
This paper references
Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
L. D. Johns (1994)
A rapid method of total lipid extraction and purification.
E. Bligh (1959)
A novel domain within the 55 kd TNF receptor signals cell death
L. A. Tartaglia (1993)
Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific‐membrane phospholipids
M. Knauer (1990)
High-efficiency transformation of mammalian cells by plasmid DNA.
C. Chen (1987)
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
J. Dignam (1983)
Bcl-2 interrupts the ceramide-mediated pathway of cell death.
J. Zhang (1996)
Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
G. Wong (1989)
Opposite effects of tumor necrosis factor alpha on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane.
A. Bettaieb (1996)
Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase.
J. Liu (1994)
FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*)
A. Chinnaiyan (1996)
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
T. Espevik (1990)
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
D. Mutch (1992)
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
H. Hsu (1995)
Tumor necrosis factors: developments during the last decade.
B. Aggarwal (1996)
Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.
C. Brakebusch (1992)
Simple and rapid fluorimetric method for DNA microassay.
J. Kapuściński (1977)
Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium‐dependent pathways in lymphoblastoid cells
I. Escargueil-Blanc (1994)
A simple method for the isolation and purification of total lipides from animal tissues.
J. Folch (1957)
Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog.
J. Preiser (1991)
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.
M. Jäättelä (1995)
A20 zinc finger protein inhibits TNF and IL-1 signaling.
M. Jäättelä (1996)
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
P. Chomczyński (1987)
Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
S. Erickson (1994)
Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
J. Rothe (1993)
Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction.
R. A. Wolff (1994)
Oncogene, in press. Alteration of SMase/Ceramide Pathway and Resistance
C.J.F. Böttcher (1961)
Programmed cell death induced by ceramide.
L. Obeid (1993)
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
K. Wiegmann (1994)
Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B.
G. Dbaibo (1993)
FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis
A. Chinnaiyan (1995)
Preparations of lymphotoxin induce resistance to their own cytotoxic effect.
D. Wallach (1984)
Bcl-2 and the regulation of programmed cell death
J. C. Reed (1994)
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
M. Tsujimoto (1985)
Ceramide Activates the Stress-activated Protein Kinases (*)
J. Westwick (1995)
FAN, a Novel WD-Repeat Protein, Couples the p55 TNF-Receptor to Neutral Sphingomyelinase
S. Adam-Klages (1996)
The development of human tumor‐cell resistance to TNF‐α does not confer resistance to cytokine‐induced cellular cytotoxic mechanisms
A. Zyad (1992)
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
R. Kolesnick (1994)
TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40
M. Rothe (1995)
Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
H. van Bronswijk (1989)
cPLA2 is phosphorylated and activated by MAP kinase
L. Lin (1993)
Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.
M. Jäättelä (1992)
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor.
M. Hayakawa (1993)
Dissociation of endogenous cellular ceramide from NF-kappa B activation.
J. Betts (1994)
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
H. Hsu (1996)
Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.
W. D. Jarvis (1994)
NF-κB: A lesson in family values
D. Thanos (1995)
Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed.
C. Joseph (1993)
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
L. A. Tartaglia (1991)
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
A. Opipari (1992)
Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells.
M. Raines (1993)
Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha.
S. Jayadev (1994)
Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
Z. Yang (1993)
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
W. Fiers (1991)
Introduction: sphingolipids and their metabolites in cell regulation.
A. Merrill (1993)
Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis.
B. Vanhaesebroeck (1992)
A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*)
M. Boldin (1995)
Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.
L. A. Tartaglia (1993)
A rapid and sensitive sub-micro phosphorus determination
C. Böttcher (1961)
Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor
L. A. Tartaglia (1993)
[Tumor necrosis factor: pleiotropic cytokine].
S. Chouaib (1992)
The sphingomyelin cycle and the second messenger function of ceramide.
Y. Hannun (1994)
This paper is referenced by
Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells Published, JLR Papers in Press, December 2, 2005.
R. Pérez (2006)
Ceramide-driven stress signals in cancer and aging
P. Ruvolo (2003)
Glucosylceramide Synthase Does Not Attenuate the Ceramide Pool Accumulating during Apoptosis Induced by CD95 or Anti-cancer Regimens*
A. D. Tepper (2000)
Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosis.
Y. Liu (2004)
Tumor necrosis factor-α and ceramide induce cell death through different mechanisms in rat mesangial cells.
Y. Guo (1999)
Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
S. Di Bartolomeo (2001)
The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells
F. Alam (2017)
Antineoplastic properties of arachidonic acid and its metabolites.
A. Monjazeb (2002)
Effects of Environmental Estrogen on Apoptosis in Normal and Cancerous Breast Epithelial Cells
M. Burow (1999)
Effect of Loxosceles gaucho venom on cell morphology and behaviour in vitro in the presence and absence of sphingomyelin.
M. O. Domingos (2003)
Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria
M. Ameyar-Zazoua (2002)
Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells*
T. Kottke (2002)
Sphingolipids and Cancer
E. Schmelz (2006)
Sphingolipids as Chemopreventive Agents
E. Schmelz (2005)
JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis.
R. Doman (1999)
Molecular mechanisms of ionizing radiation‐induced apoptosis
D. Watters (1999)
The metabolism and function of sphingolipids and glycosphingolipids
S. Lahiri (2007)
Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment.
A. P. Struckhoff (2010)
Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor–induced apoptosis
S. Rayala (2006)
Activities and interactions among phospholipases A2 during thapsigargin-induced S49 cell death
H. A. Wilson (2004)
Breast Cancer Foundation ( to L . L . ) Supported in part by grantsPathways to Induce Apoptosis 1 Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Novel Extranuclear-targeted Anthracyclines Override the Updated
F. Lewis (2014)
Regulation of sphingomyelin metabolism.
Kamil Bienias (2016)
Lysosomal sphingomyelinase is not solicited for apoptosis signaling
C. Bezombes (2001)
Novel Ceramide Analogs as Potential Chemotherapeutic Agents in Breast Cancer
A. P. Struckhoff (2004)
Inhibition of Hormone Dependent and Independent Breast Cancer Cells by Oyster(Crassostrea virginica) Ceramide
Madhavi Chintalapati (2006)
Sphingomyelin hydrolysis during apoptosis.
N. Andrieu-Abadie (2002)
Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells.
M. Davis (2000)
The actin filament cross-linker L-plastin confers resistance to TNF-α in MCF-7 breast cancer cells in a phosphorylation-dependent manner
B. Janji (2010)
SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
M. Cabot (1999)
Synergistic stimulation of MHC class I and IRF‐1 gene expression by IFN‐γ and TNF‐α in oligodendrocytes
C. Agresti (1998)
Ceramide in Apoptosis: A Revisited Role
T. Levade (2004)
Ceramide and Multidrug Resistance
M. Cabot (2007)See more